Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: May 13, 2011

Premium

Waters this week named the Proteomics Core Facility at the Duke University School of Medicine one of its Centers of Innovation and recognized the facility's director Arthur Moseley for his research.

The Duke Proteomics Core serves the Duke University of School of Medicine, the Insitute for Genome Sciences & Policy, and the Duke Cancer Institute with protein characterization resources.

The Waters Centers of Innovation Program is meant to recognize and support the efforts of scientists using mass spec and LC to make scientific breakthroughs, the company said.

Waters also this week appointed William Curry, who currently serves as company VP and corporate controller, to the post of principal accounting officer. Curry has been at the firm as a corporate controller since 1999.


Proteros Biostructures has appointed David Lemus to take over the role of chairman of the board, and Rainer Metternich to be deputy chairman of the board, the protein structure and analysis company said this week.

Lemus formerly was executive VP and CFO at MorphoSys, where he spent 13 years and helped the firm become a public company. Metternich, who previously was VP and basic research site head at Merck, and is currently chief operating officer and chief business officer at Caprotec Bioanalytics, will head Proteros' R&D/Lead Discovery committee.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.